COMMUNIQUÉS West-GlobeNewswire

Specialty Renal Products Announces $3 Million Series A Financing
06/09/2018
SOUTH ORANGE, NJ, Sept. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a private medical device company focused on the development of products for patients with renal disease, [...]
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
06/09/2018
SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the appointment of Hubert C [...]
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
06/09/2018
6 of 8 pts (75%) ORR in treatment-naïve EGFR mutation-positive NSCLC patients Well-tolerated with unremarkable safety profile; No DLTs or related SAEs Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC [...]
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City.
06/09/2018
RALEIGH, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory [...]
Orphazyme to Present at BioCentury 25th Annual NewsMakers in the Biotech Industry
06/09/2018
Orphazyme A/S Investor news No. 09/2018 Company Registration No. 32266355 Copenhagen, September 6, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
UPDATE: Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada
06/09/2018
Emblem brands and products to be distributed through Compass’ national retail operations, Starbuds Canada TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), [...]
Intrommune Therapeutics Completes Pre-IND Meeting With FDA on INT301 for Peanut Allergy
06/09/2018
New York, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food allergies, today announced [...]
CMS Rating for Amedisys Home Health Improves for 11th Consecutive Quarter
06/09/2018
BATON ROUGE, La., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of the nation’s leading home healthcare, hospice and personal care companies, received an average rating of 4.38 Stars out of a [...]
Cutera Announces Regulatory Clearance of truSculpt® iD in Canada
06/09/2018
BRISBANE, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard
06/09/2018
Highlights: Global 230 patient (8 sites) study confirms Medibio’s Depression Diagnostic Aide (DX04) With 70% accuracy, 70% sensitivity and 71% specificity results demonstrate utility in long-term monitoring Study [...]
Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets
06/09/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets Discovery Enabled by Discuva Platform and Proprietary Bacterial Libraries [...]
BeyondSpring’s Lead Asset, Plinabulin, Shows Superior Efficacy Compared to Neulasta for Prevention of Thrombocytopenia Induced by Docetaxel in Phase 2 Trial
06/09/2018
Data Provide Further Support for Plinabulin’s Superior Product Profile Clinical Data Will be Presented at 2018 IASLC 19th World Conference on Lung Cancer NEW YORK , Sept. 06, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc [...]
Auxly and Delta 9 Announce Strategic Investment and Supply Agreement
06/09/2018
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX:CBWTF) (" Auxly ") and Delta 9 Cannabis Inc. (TSX.V -NINE) (“ Delta 9 ”) are pleased to announce that the [...]
CDC Awards BioCryst $35 Million RAPIVAB® Contract for Strategic National Stockpile
06/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]
Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis Growing Facilities in the World
06/09/2018
Entire first half of 1.1 million square foot Delta 3 greenhouse now approved for cultivation and sale VICTORIA, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX: [...]
Oncolytics Biotech® Announces a Master Clinical Supply Agreement of an Anti-PD-L1 Checkpoint Inhibitor for use in the Company’s Clinical Program
06/09/2018
CALGARY, Alberta and SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
TRU NIAGEN® to be Highlighted at Vitafoods Asia 2018 in Singapore
06/09/2018
Amy Boileau, PhD, RD, to speak on the revolutionary science behind TRU NIAGEN to Asia-Pacific nutraceutical industry IRVINE, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, [...]
Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy
06/09/2018
Single, Pivotal Phase 3 Clinical Trial in Approximately 20 KCNQ2-EE Patients Expected to be Initiated in Mid-2019 Conference Call Today at 8:00 am ET Xenon to Webcast Update on Epilepsy Pipeline from Biocentury [...]
Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise
06/09/2018
Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise The acquisition of sanaplasma AG will extend long-term plasma supply in support of Shire’s growing Immunology business sanaplasma [...]

Pages